MOLN - Molecular Partners AG ADR
Molecular Partners AG ADR Logo

MOLN - Molecular Partners AG ADR

https://www.molecularpartners.com
Momentum: Bearish
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Molecular Partners AG is a clinical-stage biopharmaceutical company. The company is headquartered in Schlieren, Switzerland.

52W High
$7.60
52W Low
$3.36

MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.48
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
1.78
EV/EBITDA (<8 favorable)
1.24
EV/Revenue (<3 favorable)
3.81
P/S (TTM) (<3 favorable)
197.75
P/B (<3 favorable)
1.01
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
0.00%
Institutions (25–75% balanced)
9.73%
Shares Outstanding
37,392,400
Float
15,404,200
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
681,000
Gross Profit (TTM)
-42,259,000
EPS (TTM)
-2.23
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-88.43%
ROE (TTM) (>15% strong)
-0.49%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-1.00
Momentum
Bearish momentum
Value
0.0189
Previous
0.0194
Trend
Falling
Signal Cross
No cross

As of
Sep. 12, 2025